Total Payments
$3,815
2024 Payments
$1,133
Companies
22
Transactions
138
Medicare Patients
4,377
Medicare Billing
$251,016
Payment Breakdown by Category
Food & Beverage$3,815 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,815 | 138 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,116 | 41 | $0 (2024) |
| Johnson & Johnson Vision Care, Inc. | $393.51 | 20 | $0 (2024) |
| Alcon Vision LLC | $370.65 | 9 | $0 (2024) |
| Glaukos Corporation | $347.84 | 3 | $0 (2024) |
| Allergan, Inc. | $236.31 | 16 | $0 (2022) |
| Bausch & Lomb Americas Inc. | $224.19 | 11 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $223.75 | 7 | $0 (2021) |
| Tarsus Pharmaceuticals, Inc. | $140.83 | 2 | $0 (2024) |
| CooperVision Inc. | $127.52 | 7 | $0 (2024) |
| Ocular Therapeutix, Inc. | $98.05 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,133 | 30 | Glaukos Corporation ($227.32) |
| 2023 | $1,071 | 40 | AbbVie Inc. ($517.34) |
| 2022 | $670.56 | 27 | ABBVIE INC. ($394.82) |
| 2021 | $571.97 | 28 | Allergan, Inc. ($219.72) |
| 2020 | $71.56 | 3 | Alcon Vision LLC ($39.60) |
| 2019 | $109.67 | 5 | Bausch & Lomb, a division of Bausch Health US, LLC ($67.56) |
| 2018 | $172.45 | 4 | Bausch & Lomb, a division of Bausch Health US, LLC ($96.68) |
| 2017 | $15.26 | 1 | Alcon Laboratories Inc ($15.26) |
All Payment Transactions
138 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Ophthalmology | ||||||
| 12/17/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: EYE CARE | ||||||
| 10/23/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/27/2024 | Johnson & Johnson Vision Care, Inc. | — | Food and Beverage | In-kind items and services | $4.37 | General |
| 09/25/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $85.79 | General |
| Category: Glaucoma | ||||||
| 09/19/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: EYE CARE | ||||||
| 08/20/2024 | Johnson & Johnson Vision Care, Inc. | — | Food and Beverage | In-kind items and services | $27.17 | General |
| 08/09/2024 | Johnson & Johnson Vision Care, Inc. | — | Food and Beverage | In-kind items and services | $13.85 | General |
| 07/25/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $98.05 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 07/23/2024 | Tarsus Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $127.28 | General |
| 06/13/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: EYE CARE | ||||||
| 06/04/2024 | Johnson & Johnson Vision Care, Inc. | — | Food and Beverage | In-kind items and services | $31.63 | General |
| 05/09/2024 | Johnson & Johnson Vision Care, Inc. | — | Food and Beverage | In-kind items and services | $20.97 | General |
| 05/03/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $6.07 | General |
| Category: EYE CARE | ||||||
| 04/29/2024 | Alcon Vision LLC | DAILIES TOTAL1 (Device) | Food and Beverage | In-kind items and services | $133.15 | General |
| Category: Ophthalmology | ||||||
| 04/24/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $90.98 | General |
| Category: EYE CARE | ||||||
| 04/23/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Ophthalmology | ||||||
| 04/23/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Dry eyes | ||||||
| 04/11/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/03/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Food and Beverage | Cash or cash equivalent | $141.53 | General |
| Category: Corneal Health | ||||||
| 03/28/2024 | Johnson & Johnson Vision Care, Inc. | — | Food and Beverage | In-kind items and services | $16.98 | General |
| 03/26/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: Ophthalmology | ||||||
| 03/18/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Ophthalmology | ||||||
| 03/05/2024 | CooperVision Inc. | MyDay Contact Lens (Device) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Devices | ||||||
| 02/23/2024 | Johnson & Johnson Vision Care, Inc. | — | Food and Beverage | In-kind items and services | $27.53 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,014 | 1,197 | $134,815 | $56,592 |
| 2022 | 7 | 1,004 | 1,159 | $144,756 | $55,727 |
| 2021 | 9 | 1,219 | 1,486 | $160,574 | $77,318 |
| 2020 | 11 | 1,140 | 1,239 | $161,370 | $61,380 |
Total Patients
4,377
Total Services
5,081
Medicare Billing
$251,016
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 263 | 374 | $37,400 | $20,427 | 54.6% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 249 | 252 | $50,400 | $18,751 | 37.2% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 190 | 204 | $20,400 | $7,751 | 38.0% |
| 92133 | Imaging of optic nerve | Office | 2023 | 231 | 283 | $16,980 | $6,203 | 36.5% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 29 | 29 | $6,960 | $2,402 | 34.5% |
| 92134 | Imaging of retina | Office | 2023 | 32 | 35 | $2,275 | $907.00 | 39.9% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 20 | 20 | $400.00 | $150.81 | 37.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 284 | 286 | $53,554 | $20,845 | 38.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 243 | 347 | $39,289 | $18,199 | 46.3% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 173 | 184 | $21,658 | $7,010 | 32.4% |
| 92133 | Imaging of optic nerve | Office | 2022 | 215 | 251 | $18,194 | $5,391 | 29.6% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 39 | 39 | $9,075 | $3,306 | 36.4% |
| 92134 | Imaging of retina | Office | 2022 | 30 | 32 | $2,414 | $856.82 | 35.5% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 20 | 20 | $573.00 | $118.80 | 20.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 274 | 448 | $46,230 | $28,005 | 60.6% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 305 | 313 | $55,185 | $25,219 | 45.7% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 215 | 248 | $23,670 | $10,472 | 44.2% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 251 | 294 | $17,190 | $7,328 | 42.6% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 39 | 39 | $8,415 | $3,512 | 41.7% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 42 | 47 | $2,969 | $1,221 | 41.1% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 30 | 31 | $4,135 | $783.27 | 18.9% |
| 76514 | Ultrasound of corneal structure and measurement | Office | 2021 | 51 | 52 | $1,380 | $401.59 | 29.1% |
| 92250 | Photography of the retina | Office | 2021 | 12 | 14 | $1,400 | $375.83 | 26.8% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 252 | 256 | $47,350 | $21,113 | 44.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 237 | 284 | $35,758 | $13,415 | 37.5% |
About Samantha Devlin
Samantha Devlin is a Optometrist healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2016. The National Provider Identifier (NPI) number assigned to this provider is 1750732616.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Samantha Devlin has received a total of $3,815 in payments from pharmaceutical and medical device companies, with $1,133 received in 2024. These payments were reported across 138 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,815).
As a Medicare-enrolled provider, Devlin has provided services to 4,377 Medicare beneficiaries, totaling 5,081 services with total Medicare billing of $251,016. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Other Specialties Optometrist
- Location Dallas, TX
- Active Since 06/22/2016
- Last Updated 07/21/2022
- Taxonomy Code 152W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1750732616
Products in Payments
- DURYSTA (Drug) $881.96
- Acuvue (Device) $220.33
- VUITY (Drug) $182.72
- ALPHAGAN P (Drug) $172.36
- CE-marked KXLA system (Device) $141.53
- DAILIES TOTAL1 (Device) $133.15
- MyDay Contact Lens (Device) $127.52
- KXL System (Device) $120.52
- LUMIGAN (Drug) $114.14
- STELLARIS (Device) $100.48
- HYDRUS Microstent (Device) $100.31
- DEXTENZA (Drug) $98.05
- TEPEZZA (Drug) $97.95
- iDose (Device) $85.79
- BIOTRUE (Device) $81.98
- INFUSE (Device) $76.89
- DAILIES (Device) $75.05
- EYLEA HD (Biological) $71.24
- MIEBO (Drug) $69.63
- TOTAL30 (Device) $64.77
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Dallas
Dr. Laurence Thomas, O.d, O.D
Optometrist — Payments: $163,565
Optometrist $163,565
Kenneth Uzick, O.d, O.D
Optometrist — Payments: $61,059
Optometrist $61,059
Amanda Hoelscher, Od, OD
Optometrist — Payments: $16,203
Optometrist $16,203
Dr. Linda Hatton, O.d, O.D
Optometrist — Payments: $14,670
Optometrist $14,670
Dr. Slayton Ebeling, O.d, O.D
Optometrist — Payments: $13,635
Optometrist $13,635
Michael Burton, Od, OD
Optometrist — Payments: $12,447
Optometrist $12,447